abacavir

Generic: abacavir

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name abacavir
Generic Name abacavir
Labeler camber pharmaceuticals, inc.
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

abacavir sulfate 20 mg/mL

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-562
Product ID 31722-562_34da1f28-8687-4286-a674-ac3cb61440f5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA201107
Listing Expiration 2026-12-31
Marketing Start 2016-09-26

Pharmacologic Class

Classes
human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor [epc] nucleoside analog [ext] nucleoside reverse transcriptase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722562
Hyphenated Format 31722-562

Supplemental Identifiers

RxCUI
242680
UPC
0331722562249
UNII
J220T4J9Q2

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name abacavir (source: ndc)
Generic Name abacavir (source: ndc)
Application Number ANDA201107 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 20 mg/mL
source: ndc
Packaging
  • 240 mL in 1 BOTTLE (31722-562-24)
source: ndc

Packages (1)

Ingredients (1)

abacavir sulfate (20 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "34da1f28-8687-4286-a674-ac3cb61440f5", "openfda": {"upc": ["0331722562249"], "unii": ["J220T4J9Q2"], "rxcui": ["242680"], "spl_set_id": ["e5cbf204-c10d-444b-aba0-180a30645d55"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "240 mL in 1 BOTTLE (31722-562-24)", "package_ndc": "31722-562-24", "marketing_start_date": "20160926"}], "brand_name": "Abacavir", "product_id": "31722-562_34da1f28-8687-4286-a674-ac3cb61440f5", "dosage_form": "SOLUTION", "pharm_class": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Analog [EXT]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "31722-562", "generic_name": "Abacavir", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Abacavir", "active_ingredients": [{"name": "ABACAVIR SULFATE", "strength": "20 mg/mL"}], "application_number": "ANDA201107", "marketing_category": "ANDA", "marketing_start_date": "20160926", "listing_expiration_date": "20261231"}